Trial intelligence / Profile preview

CollaRx Bupivacaine Implant in Post-GI Surgery Pain

NCT00661466Phase 2Terminated

Sponsor
Innocoll
Start
Jul 2008
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative pain comparing CollaRx Bupivacaine Implant with Placebo Implant (2 arms). Primary endpoint: Total Amount of Opioid Rescue Analgesia Used. Started Jul 2008; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00661466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00661466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call